Who are Oculis's investors?

Oculis's investors include Bay City Capital, Brunnur Ventures GP, Pivotal Life Sciences, VI Partners, BVCF.

Where is Oculis headquartered?

Oculis is headquartered in Boston, CH.

Oculis

Boston, CH · 5 known investors

Find your way into Oculis

680 people in our graph share verified history with the Oculis team — schools, employers, funds. One of them is your warm intro.

Bart Dzikowskiunlockedknows Riad Sherif · together at Oculis (overlapped)

×2knows the team · via Oculis

×3knows the team · via IMD

×4knows the team · via Harvard Business School

×2knows the team · via Alcon

Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments. It conducts formulation, process, and analytical development to advance drug candidates from early research through later development stages.

Biotech Healthtech Medical Devices

Founders & leadership

Riad Sherif Chief Executive OfficerChief Executive Officer of Oculis, a biopharmaceutical company developing treatments for ophthalmic diseases affecting the front and back of the eye.

Investors · 5

Bay City Capitallisted by Bay City CapitalSan Rafael · $5M – $10M

Brunnur Ventures GPlisted by Brunnur Ventures GPReykjavik · $1M – $3M

How we know: Brunnur Ventures GP's portfolio page · Not right? Tell us

Pivotal Life Scienceslisted by Pivotal Life SciencesSan Francisco

How we know: Pivotal Life Sciences's portfolio page · a partner's Signal profile · Not right? Tell us

VI Partnerslisted by VI PartnersAltendorf · $2.2M – $4.5M

How we know: VI Partners's portfolio page · Not right? Tell us

BVCFreportedShanghai · $5M

How we know: a partner's Signal profile · Not right? Tell us

Competitors · 2

by search overlap

Ois38 shared keywordsOIS is a conference and community, active since 2009, focused on eye care and ophthalmology innovation, connecting startups, strategics, investors, and clinicians. It provides curated programming, networking, and access to new technologies in the ophthalmology industry.

Medscape34 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with Oculis for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Oculis do?: Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments. It conducts formulation, process, and analytical development to advance drug candidates from early research through later development stages.
Who are Oculis's investors?: Oculis's investors include Bay City Capital, Brunnur Ventures GP, Pivotal Life Sciences, VI Partners, BVCF.
Where is Oculis headquartered?: Oculis is headquartered in Boston, CH.